Welcome to LookChem.com Sign In|Join Free

CAS

  • or

135042-29-4

Post Buying Request

135042-29-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

135042-29-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 135042-29-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,0,4 and 2 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 135042-29:
(8*1)+(7*3)+(6*5)+(5*0)+(4*4)+(3*2)+(2*2)+(1*9)=94
94 % 10 = 4
So 135042-29-4 is a valid CAS Registry Number.

135042-29-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 9-[(3R,5R)-5-(hydroxymethyl)pyrrolidin-3-yl]-3H-purin-6-one

1.2 Other means of identification

Product number -
Other names (3R,5R)-1,9-dihydro-9-[5-(hydroxymethyl)-3-pyrrolidinyl]-6H-purin-6-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:135042-29-4 SDS

135042-29-4Downstream Products

135042-29-4Relevant articles and documents

Synthesis and Biological Evaluation of 4-Purinylpyrrolidine Nucleosides

Peterson, Mark L.,Vince, Robert

, p. 2787 - 2797 (2007/10/02)

The synthesis of several novel carbocyclic purine nucleosides that incorporate a nitrogen in place of carbon 3 of the cyclopentyl moiety are described.These analogues are all derived from the key stereochemically defined intermediate N-(tert-butoxycarbonyl)-O--trans-4-hydroxy-D-prolinol (19), which was accessible in 61.1percent overall yield for a five-step sequence starting from cis-4-hydroxy-D-proline.The heterocyclic bases, 6-chloropurine and 2-amino-6-chloropurine, are efficiently introduced onto the pyrrolidine ring via a Mitsunobu-type coupling procedure with triphenylphosphine and diethyl azodicarboxylate.Standard transformations and removal of protecting groups gave the cis-adenine (26), hypoxanthine (27), 2,6-diaminopurine (28), and guanine (29) D-prolinol derivatives.In addition, a related sequence from trans-4-hydroxy-L-proline provided the enantiomeric L-prolinol guanine derivative (36).Lastly, the 6-(dimethylamino)purine analogue, 37, was coupled to N-(benzyloxycarbonyl)-p-methoxy-L-phenylalanine to provide, after deprotection, the novel puromycin-like analogue 39.The analogues 26-29, 36, and 39 were all evaluated for antitumor and, except for 39, for antiviral activity.These compounds failed to appreciably inhibit the growth of P388 mouse leukemia cells in vitro at concentrations up to 100 μg/mL.In addition, they did not exhibit noticeable activity against the human immunodeficiency virus or herpes simplex virus type 1 at concentrations as high as 100 μM.The adenine analogue, 26, did, however, prove to be a substrate for adenosine deaminase.It possessed an affinity for the enzyme only 50percent less than that of adenosine with a Ki = 85 μM.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 135042-29-4